MPLT

Conviction 0HealthcareScan · Mon, Aug 10, 2026

MPLT$12.18+0.08%

ResistanceSupportVol 14Insider buyInsider sell

Vol MA14 1.91M

May 11May 28Jun 16Jul 6Jul 23Aug 10

MapLight Therapeutics, Inc.Biotechnologywww.maplightrx.com ↗

Price12.18

Change+0.08%

Gap-9.78%

Rel volume0.57×

Avg volume1.53M

Avg $ vol24.98M

SMA 2023.56

SMA 5028.52

SMA 200—

Price vs 50-57.29%

Price vs 200—

MA stack—

50/200 cross—

Supertrenddown · 20.01

RSI (14)29

MACD hist-1.11

MACD cross—

Stoch %K / %D11 / 12

ADX (14)45

+DI / −DI13 / 40

RSI divergence—

MACD divergence—

ATR %+23.81%

ADR %11.82%

52w high39.80

52w low9.91

From 52w high-69.40%

Above 52w low+22.97%

New 52w highNo

SqueezeOff

Bollinger width203.65%

%B0.26

Donchian pos10.33%

Donchian high38.93

Donchian low9.10

AVWAP (52w high)17.62

vs AVWAP high-30.87%

AVWAP (52w low)12.91

vs AVWAP low-5.67%

OBV trendDown

Chaikin MF (20)-0.09

Today vs 20d0.57×

Avg vol (14d)1.91M

Avg vol (20d)1.53M

Avg $ vol (20d)24.98M

Market cap516.87M

RS 3m (vs SPY)-64.02%

RS 6m (vs SPY)-36.60%

RS line new highNo

Trend template—

Technical rank5.7

1 week-2.95%

1 month-69.02%

3 months-55.55%

6 months-28.27%

1 year—

YTD-27.37%

P/E-3.21

P/B1.29

P/S—

P/FCF-3.73

EPS-18.56

Div yield—

ROE-40.30%

ROA-38.48%

Debt/Eq—

Current22.91

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth-107.72%

Price target28.91

Target upside137.36%

Analyst ratingBuy

Institutional60.71%

Ent. value461.17M

Revenue—

Net income-60.67M

Gross profit—

Free cash flow-138.61M

IndustryBiotechnology

ExchangeNasdaq

Shares out42.62M

Employees133

ListedMon, Oct 27, 2025

Free float18.66M

Float %41.1%

Short interest3.59M

Days to cover6.7d

Short volume77.8%

Squeeze score83 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$1.34 vs −$0.91

Last surprise-47.3% miss

Setup gradeD

Conviction0 / 100

Pattern quality—

Tech rank5.7 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance39.68

Support10.59

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in MPLT

All disclosures →

No recent disclosed trades by Congress in MPLT. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in MPLT · 1 buy · 9 sells

Insider	Side	Shares	Value	Traded	Filed
Cox Troy Director · Voting Common Stock · 2026-07-28	Buy	15.62K	$149K	2026-07-28	2026-07-28
Kroeger Christopher A. Chief Executive Officer · Voting Common Stock · 2026-07-17	Sell	16.78K	$636K	2026-07-17	2026-07-17
Lillie James Woodruff Chief Scientific Officer · Voting Common Stock · 2026-07-17	Sell	2.08K	$79K	2026-07-17	2026-07-17
Foff Erin Pennock Chief Medical Officer · Voting Common Stock · 2026-07-17	Sell	3.66K	$139K	2026-07-17	2026-07-17
Hanson Kristopher General Counsel · Voting Common Stock · 2026-07-17	Sell	1.13K	$43K	2026-07-17	2026-07-17
Foff Erin Pennock Chief Medical Officer · Voting Common Stock · 2026-07-16	Sell	19	$721	2026-07-16	2026-07-17
Hanson Kristopher General Counsel · Voting Common Stock · 2026-07-16	Sell	4.78K	$174K	2026-07-16	2026-07-17
Lillie James Woodruff Chief Scientific Officer · Voting Common Stock · 2026-07-16	Sell	5.01K	$183K	2026-07-16	2026-07-17
Lillie James Woodruff Chief Scientific Officer · Voting Common Stock · 2026-07-16	Sell	3.53K	$131K	2026-07-16	2026-07-17
Lillie James Woodruff Chief Scientific Officer · Voting Common Stock · 2026-07-16	Sell	12	$456	2026-07-16	2026-07-17

SEC filings

EDGAR filings in MPLT · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.